Inspire Medical Systems Inc (INSP) Stock Forecast & Price Target
Inspire Medical Systems Inc · NYSE
$52.05+1.12 (+2.20%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 18 firms covering Inspire Medical Systems Inc, 4 rate it Buy or better, 14 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $40.00 to $91.00 (about 2.3x), a sign of real disagreement on valuation. The average target of $57.75 sits 11% above the current $52.05. The rating mix has stayed broadly stable, with Buy-side ratings easing from 6 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.13 next quarter toward $1.26 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS18 ratings
Moderate Buy
Strong Buy00%
Buy422%
Hold1478%
Sell00%
Strong Sell00%
Based on 18 analysts giving stock ratings to Inspire Medical Systems Inc.
As of Jul, 4 of 18 firms rate INSP a Buy (14 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
INSP EPS & revenue forecast
EPS · NEXT QUARTER
$0.13
Range $-0.06 – $0.35 · 13 analysts · -66% YoY
Next period, 13 analysts expect Inspire Medical Systems Inc to earn $0.13 a share (range $-0.06 – $0.35), versus $0.38 a year earlier. Full-year consensus is $0.90, growing to $1.26 the year after.
REVENUE · NEXT QUARTER
$203.0M
Range $200.5M – $206.0M · 13 analysts · -10% YoY
Revenue is expected to reach $203.0M (range $200.5M – $206.0M), -9.6% year-over-year. Full-year consensus is $843.3M, rising to $875.6M next year.
Top analysts covering Inspire Medical Systems Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on INSP.
#1
Jonathan Block
Stifel · Rank #172
Buy
$65.00+24.9% to target
Overall win rate
42%
+ Follow
#2
Frank Takkinen
Lake Street · Rank #327
Buy
$150.00+188.2% to target
Overall win rate
26%
+ Follow
#3
Richard Newitter
Truist Securities
Hold
$54.00+3.7% to target
Coverage
—
+ Follow
#4
Anthony Petrone
Mizuho
Buy
$55.00+5.7% to target
Coverage
—
+ Follow
#5
LB
Larry Biegelsen
Wells Fargo
Hold
$56.00+7.6% to target
Coverage
—
+ Follow
INSP stock forecast FAQ
What is INSP's average 12-month price target?+
The 12 analysts with a live target average $57.75 for Inspire Medical Systems Inc over the next 12 months, ranging from a $91.00 high to a $40.00 low.
Is INSP stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 18 analyst ratings, 4 are Buy or Strong Buy, 14 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for INSP?+
The Street-high target is $91.00 (UBS), and the Street-low is $40.00 (Evercore ISI Group). The average of all 12 active targets is $57.75.
How many Wall Street analysts cover INSP?+
18 analysts have an active rating on Inspire Medical Systems Inc, and 12 firms carry a live 12-month price target.
Who is the most accurate analyst covering INSP?+
Among analysts who currently cover INSP, Jonathan Block of Stifel has the strongest overall Quantellect track record (Rank #172). Their current call is Buy with a $65.00 target.
What is Inspire Medical Systems Inc's projected EPS for next quarter?+
The consensus estimate is $0.13 per share (range $-0.06 – $0.35) across 13 analysts. Full-year EPS is projected at $0.90, rising to $1.26 the following year.
How much revenue is Inspire Medical Systems Inc expected to report next quarter?+
Consensus revenue is $203.0M (range $200.5M – $206.0M). Full-year revenue is projected at $843.3M, growing to $875.6M next year.
Have analysts been upgrading or downgrading INSP lately?+
As of Jul, 4 of 18 firms rate INSP a Buy (14 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their INSP calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
